Vimarsana
Biggest News Aggregation in the World

Transitional Pass Through Payment News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Transitional Pass Through Payment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Transitional Pass Through Payment Today - Breaking & Trending Today

Why Is Heart Failure-Focused CVRx Stock Trading Higher Today? - CVRx (NASDAQ:CVRX) - Vimarsana News

Why Is Heart Failure-Focused CVRx Stock Trading Higher Today? - CVRx (NASDAQ:CVRX)

CVRx Inc (NASDAQ: CVRX) announced that the Centers for Medicare and Medicaid Services (CMS) has reassigned the Barostim implant procedure for procedures performed in the outpatient setting as part of the 2024 Medicare Hospital Outpatient Prospective Payment System 

Saluda Medical Initiates U.S. Commercialization of the Evoke® Spinal Cord Stimulation System - Vimarsana News

Saluda Medical Initiates U.S. Commercialization of the Evoke® Spinal Cord Stimulation System

/PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical"), a global medical device company revolutionizing the field of neuromodulation, today announced it...

Saluda Medical Initiates U.S. Commercialization of the Evoke® Spinal Cord Stimulation System - Vimarsana News

Saluda Medical Initiates U.S. Commercialization of the Evoke® Spinal Cord Stimulation System

/PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical"), a global medical device company revolutionizing the field of neuromodulation, today announced it...

Telix Reports Second Quarter 2022 Financial Results - Vimarsana News

Telix Reports Second Quarter 2022 Financial Results

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
VenoStent Technology Receives Breakthrough Device Designation by FDA - Vimarsana News

VenoStent Technology Receives Breakthrough Device Designation by FDA

Designation to promote more rapid Agency and market access for VenoStentHOUSTON, TX / ACCESSWIRE / May 17, 2022 / VenoStent, Inc., a clinical-stage tissue engineering company developing bioabsorbable perivascular